Patient Group Direction for COVID-19 Vaccine AstraZeneca, (ChAdOx1-S [recombinant])

This PGD is for the administration of COVID-19 Vaccine AstraZeneca by registered healthcare practitioners to individuals in accordance with the national COVID-19 vaccination programme.

Source:

NHS England